Strategic Global Advisors, LLC Dr Reddys Laboratories LTD Transaction History

Strategic Global Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$62.12 - $74.2 $1.61 Million - $1.93 Million	-25,994 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$57.98 - $73.08 $890,804 - $1.12 Million	-15,364 Reduced 37.15%	25,994 $1.6 Million
Q4 2020 Feb 16, 2021	SELL	$62.61 - $71.29 $715,757 - $814,987	-11,432 Reduced 21.66%	41,358 $2.95 Million
Q3 2020 Nov 13, 2020	BUY	$51.39 - $72.41 $1.75 Million - $2.47 Million	34,140 Added 183.06%	52,790 $3.67 Million
Q2 2020 Aug 13, 2020	SELL	$39.55 - $54.65 $140,402 - $194,007	-3,550 Reduced 15.99%	18,650 $989,000

Q1 2020 May 14, 2020	BUY	$34.75 - $45.85 $394,065 - $519,939	11,340 Added 104.42%	22,200 $895,000
Q4 2019 Feb 13, 2020	BUY	$36.66 - $41.78 $398,127 - $453,730	10,860 New	10,860 $441,000

242

23.6M

25.2K

8.5K

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $13B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

Get notified when there are updates to the investment portfolio of Strategic Global Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Strategic Global Advisors, LLC with notifications on news.